276 related articles for article (PubMed ID: 30474719)
1. Folate receptor-targeted novel boron compound for boron neutron capture therapy on F98 glioma-bearing rats.
Kanemitsu T; Kawabata S; Fukumura M; Futamura G; Hiramatsu R; Nonoguchi N; Nakagawa F; Takata T; Tanaka H; Suzuki M; Masunaga SI; Ono K; Miyatake SI; Nakamura H; Kuroiwa T
Radiat Environ Biophys; 2019 Mar; 58(1):59-67. PubMed ID: 30474719
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
3. Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP).
Nishimura K; Kashiwagi H; Morita T; Fukuo Y; Okada S; Miura K; Matsumoto Y; Sugawara Y; Enomoto T; Suzuki M; Nakai K; Kawabata S; Nakamura H
J Control Release; 2023 Aug; 360():249-259. PubMed ID: 37356755
[TBL] [Abstract][Full Text] [Related]
4. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
6. Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.
Yang W; Barth RF; Wu G; Huo T; Tjarks W; Ciesielski M; Fenstermaker RA; Ross BD; Wikstrand CJ; Riley KJ; Binns PJ
J Neurooncol; 2009 Dec; 95(3):355-365. PubMed ID: 19588228
[TBL] [Abstract][Full Text] [Related]
7. Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.
Wu G; Yang W; Barth RF; Kawabata S; Swindall M; Bandyopadhyaya AK; Tjarks W; Khorsandi B; Blue TE; Ferketich AK; Yang M; Christoforidis GA; Sferra TJ; Binns PJ; Riley KJ; Ciesielski MJ; Fenstermaker RA
Clin Cancer Res; 2007 Feb; 13(4):1260-8. PubMed ID: 17317838
[TBL] [Abstract][Full Text] [Related]
8. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448
[TBL] [Abstract][Full Text] [Related]
9. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.
Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH
J Neurooncol; 1997 May; 33(1-2):59-70. PubMed ID: 9151224
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.
Kashiwagi H; Kawabata S; Yoshimura K; Fukuo Y; Kanemitsu T; Takeuchi K; Hiramatsu R; Nishimura K; Kawai K; Takata T; Tanaka H; Watanabe T; Suzuki M; Miyatake SI; Nakamura H; Wanibuchi M
Invest New Drugs; 2022 Apr; 40(2):255-264. PubMed ID: 34816337
[TBL] [Abstract][Full Text] [Related]
11. Water-Soluble
Nakagawa F; Kawashima H; Morita T; Nakamura H
Cells; 2020 Jul; 9(7):. PubMed ID: 32635272
[TBL] [Abstract][Full Text] [Related]
12. Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation.
Barth RF; Yang W; Coderre JA
J Neurooncol; 2003; 62(1-2):61-74. PubMed ID: 12749703
[TBL] [Abstract][Full Text] [Related]
13. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
Yang W; Barth RF; Wu G; Bandyopadhyaya AK; Thirumamagal BT; Tjarks W; Binns PJ; Riley K; Patel H; Coderre JA; Ciesielski MJ; Fenstermaker RA
Appl Radiat Isot; 2004 Nov; 61(5):981-5. PubMed ID: 15308179
[TBL] [Abstract][Full Text] [Related]
14. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.
Yang W; Barth RF; Bartus RT; Rotaru JH; Moeschberger ML; Ferketich AK; Nawrocky MM; Coderre JA; Goodman JH
Neurosurgery; 2000 Jul; 47(1):189-97; discussion 197-8. PubMed ID: 10917362
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
16. Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.
Hiramatsu R; Kawabata S; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake S; Kuroiwa T; Hao E; Vicente MG
J Pharm Sci; 2015 Mar; 104(3):962-70. PubMed ID: 25546823
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy.
Miyata S; Kawabata S; Hiramatsu R; Doi A; Ikeda N; Yamashita T; Kuroiwa T; Kasaoka S; Maruyama K; Miyatake S
Neurosurgery; 2011 May; 68(5):1380-7; discussion 1387. PubMed ID: 21273928
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
[TBL] [Abstract][Full Text] [Related]
20. Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors.
Kawabata S; Yang W; Barth RF; Wu G; Huo T; Binns PJ; Riley KJ; Ongayi O; Gottumukkala V; Vicente MG
J Neurooncol; 2011 Jun; 103(2):175-85. PubMed ID: 20848301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
